Skip to main content

GLR1075

unknown (auto-discovered: peptides-regenerative)

Also known as: GLR1075 Injection

Classification

ResearchCompound

Regulatory Status

investigational; registered trials: NCT07851688 (PHASE1)

Unofficial source

Sources

1

Review

pending review

Overview

Unknown — GLR1075 was found by open discovery on 2026-10-27 and has not been researched yet.

Evidence and limitations

Known

n/a

Unknown

  • Mechanism, dosing, safety, interactions and efficacy are unknown until research runs on this auto-discovered draft.
Study details: trial conditions, not guidance

These are the conditions researchers used in a controlled trial with medical supervision. They aren't instructions.

Doses found

Doses as found in each source, with its grade. What was found, not a direction.

Studies, trials and professional sources

n/a

Reddit, Facebook, Instagram, forums and blogs

n/a

Claims and grades

  • Not gradedGLR1075 is being studied in a registered trial: A Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of GLR1075 Injection in Healthy Trial Participants and Cirrhotic Trial Participants With Ascites and Hypoalbuminemia (NCT07851688; PHASE1; NOT_YET_RECRUITING; sponsor Gan & Lee Pharmaceuticals.; intervention "GLR1075 Injection" (DRUG)).

Sources (1)

Educational reference only — not medical advice.

What people report (anecdote)

CLINICAL DATA (from trials)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

What people report: anecdote, not evidence

Loading…

Submit a claim you saw
GLR1075: what the evidence actually says | BioStack